Fig. 1: LGALS9 (Gal-9) and melanoma. | Communications Biology

Fig. 1: LGALS9 (Gal-9) and melanoma.

From: Tumor-targeted nanodrug FSGG/siGal-9 for transdermal photothermal immunotherapy of melanoma

Fig. 1

a Cell types in tumor microenvironments identified based on the markers in Supplementary Table 2. b Immune checkpoint communications on the cells in the tumor microenvironments. c LGALS9 (Gal-9) and HAVCR2 (TIM-3) expressed in the tumors. d Expression level of LGALS9 (Gal-9), CD80/86 and CD274 (PD-L1) in primary soild SKCM (Skin cutaneous melanoma) tumors from TCGA (The Cancer Genome Atlas).

Back to article page